| Gambogenic acid |
SMMC-7721 (Hepatocellular carcinoma) |
148 |
No |
(136) |
| 5-Fluorouracil |
MDA-MB-231
(Breast cancer) |
187.2 |
No |
(137) |
| Albendazole |
HepG2 (Hepatocellular carcinoma) |
48.17 ± 0.65 |
No |
(138) |
| Imatinib
mesylate |
Hep G2 (Liver cancer) |
130.7 ± 2.92 |
CD44 via hyaluronic
acid |
(139) |
| Bedaquiline |
A549 (Lung cancer cells) |
150.2 ± 5.1 |
No |
(140) |
| Paclitaxel |
Hela (Cervical cancer) |
138.7 ± 6 |
Biotinylated cubosomes |
(98) |
| Metformin |
Hct-116 and Caco-2 (Colorectal cancer) |
110–160 |
No |
(141) |
| siRNA |
CHO (Chinese hamster ovary) |
332 |
No |
(142) |
| Doxorubicin,
213 Bi |
HeLa (Cervical cancer) |
160 ± 10 |
No |
(143) |
| Curcumin and fish
oil antioxidant |
SH-SY5Y (Neuroblastoma) |
100 nm and 400 |
No |
(144) |
| Docetaxel |
Hela (Cervical
cancer) |
174 |
Folate via folic acid |
(112) |
| Naproxen
Na |
Hela (Cervical cancer) |
200 ± 39 |
No |
(145) |
| NaYF4:Er3+,Yb3+ UCNPs |
SKOV-3 (Ovarian cancer), MeWo (Melanoma granular fibroblasts) |
163 ± 7 |
Folate
via folic acid |
(146) |
| 5-fluorouracil |
HepG2 (Hepatocellular
carcinoma) |
105.7075.47 |
No |
(147) |
| Bambusae
Caulis |
Raw 264.7 (Mouse Leukaemia) |
166–179 |
No |
(148) |
| 5-FCPhy |
MCF7 (Breast cancer), PC3 (Prostate
cancer) |
164 |
No |
(149) |
| Lumefantrine |
A549 (Lung cancer) |
259.4 ± 19 |
No |
(150) |
| Brucea javanica Oil and Doxorubicin |
MCF-7 (Breast cancer) |
<200 |
No |
(151) |
| Ce6
or TPP-Mn |
Me45 (Skin melanoma), MeWo (Melanoma fibroblasts) |
between 130 ± 1 and 162 ± 4 |
No |
(16) |
| Curcumin |
Hela (Cervical cancer) |
100–300 |
No |
(152) |
| Rapamycin |
NK-92 (Natural killer cell) |
|
No |
(153) |
| Lipopeptide |
MCF-7 (Breast
cancer), 161Br (Skin fibroblasts) |
|
No |
(154) |
| dsDNA |
CHO (Chinese hamster ovary) |
∼250–420 |
No |
(155) |
| Capecitabine, 5-FCOle |
MDA-MB-231,
4T1 (Breast cancer) |
255 |
No |
(156) |
| Copper-organo
complex |
LS174T (Colorectal cancer) |
141 |
Carcinoembryonic antigen via Affimer protein |
(13) |
| Copper-organo
complex |
MDA-MB-231 (Breast cancer), HT29 (Colorectal
cancer) |
152 |
CD44 via hyaluronic acid |
(12) |
